Mariane M A Stefani
Overview
Explore the profile of Mariane M A Stefani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uaska Sartori P, Penna G, Buhrer-Sekula S, Pontes M, Goncalves H, Cruz R, et al.
Sci Rep
. 2020 Jan;
10(1):1284.
PMID: 31992776
Host genetic susceptibility to leprosy has been intensively investigated over the last decades; however, there are no studies on the role of genetic variants in disease recurrence. A previous initiative...
2.
Gama R, de Souza M, Sarno E, de Moraes M, Goncalves A, Stefani M, et al.
PLoS Negl Trop Dis
. 2019 Jun;
13(6):e0007400.
PMID: 31181059
Background: Early detection of Mycobacterium leprae is a key strategy for disrupting the transmission chain of leprosy and preventing the potential onset of physical disabilities. Clinical diagnosis is essential, but...
3.
Reis M, Guimaraes M, Bello G, Stefani M
Front Microbiol
. 2019 Feb;
10:97.
PMID: 30804902
Intersubtype recombinants classified as circulating recombinant forms (CRFs) or unique recombinant forms (URFs) have been shown to play an important role in the complex and dynamic Brazilian HIV/AIDS epidemic. Previous...
4.
Abrahim C, Py-Daniel V, Luz S, Fraiji N, Stefani M
Transfusion
. 2018 Dec;
59(3):1044-1051.
PMID: 30566229
Background: In the Brazilian Amazon, the filarial nematode Mansonella ozzardi co-exists with malaria parasites and thick blood smear microscopy is considered the diagnostic gold standard. Transfusion of M. ozzardi microfilariae...
5.
Souza J, Crispim M, Abrahim C, Fraiji N, Kiesslich D, Stefani M
Transfusion
. 2018 Dec;
59(2):629-638.
PMID: 30499594
Background: Confidential unit exclusion (CUE) was introduced in the 1980's as an additional layer to blood safety, before highly specific and sensitive nucleic acid tests (NAT) for HIV were implemented....
6.
Costa M, Hungria E, Freitas A, Sousa A, Jampietro J, Soares F, et al.
PLoS One
. 2018 Jun;
13(6):e0196853.
PMID: 29883464
Leprosy is a complex chronic, infectious dermato-neurological disease that affects the skin and peripheral nerves especially during immuno-inflammatory episodes known as type 1/T1R and type 2/T2R reactions. This study investigated...
7.
Hungria E, Buhrer-Sekula S, Oliveira R, Aderaldo L, Pontes M, Cruz R, et al.
Front Immunol
. 2018 Jun;
9:915.
PMID: 29867930
Clinical Trial Registration: ClinicalTrials.gov, NCT00669643.
8.
Costa M, Mimura K, Freitas A, Hungria E, Sousa A, Oliani S, et al.
Microb Pathog
. 2018 Apr;
118:277-284.
PMID: 29605649
Mast cells (MCs) have important immunoregulatory roles in skin inflammation. Annexin A1 (ANXA1) is an endogenous anti-inflammatory protein that can be expressed by mast cells, neutrophils, eosinophils, monocytes, epithelial and...
9.
Benjak A, Avanzi C, Singh P, Loiseau C, Girma S, Busso P, et al.
Nat Commun
. 2018 Jan;
9(1):352.
PMID: 29367657
Leprosy is a chronic human disease caused by the yet-uncultured pathogen Mycobacterium leprae. Although readily curable with multidrug therapy (MDT), over 200,000 new cases are still reported annually. Here, we...
10.
Stefani M, Avanzi C, Buhrer-Sekula S, Benjak A, Loiseau C, Singh P, et al.
PLoS Negl Trop Dis
. 2017 Jun;
11(6):e0005598.
PMID: 28617800
Background: Since leprosy is both treated and controlled by multidrug therapy (MDT) it is important to monitor recurrent cases for drug resistance and to distinguish between relapse and reinfection as...